Laura Lynne Stockton

Array ( [id] => 1463253 [patent_doc_number] => 06350879 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-02-26 [patent_title] => 'Benziso-N (L-histidine methylester)-thiazolone, process for the preparation thereof, and use thereof for RNA polymerase inhibition' [patent_app_type] => B1 [patent_app_number] => 09/724499 [patent_app_country] => US [patent_app_date] => 2000-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2260 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/350/06350879.pdf [firstpage_image] =>[orig_patent_app_number] => 09724499 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1463258 [patent_doc_number] => 06350881 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-02-26 [patent_title] => 'Process for the preparation of 5-methoxy-4-(methylthioalkyl) 1, 3-bis(phenylmethyl)-2-imidazolidone' [patent_app_type] => B1 [patent_app_number] => 09/724501 [patent_app_country] => US [patent_app_date] => 2000-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2627 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 156 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/350/06350881.pdf [firstpage_image] =>[orig_patent_app_number] => 09724501 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4331444 [patent_doc_number] => 06313156 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-06 [patent_title] => 'Thiazole compounds as cyclic-AMP-specific phosphodiesterase inhibitors' [patent_app_type] => 1 [patent_app_number] => 9/723091 [patent_app_country] => US [patent_app_date] => 2000-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10807 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 419 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/313/06313156.pdf [firstpage_image] =>[orig_patent_app_number] => 723091 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1350902 [patent_doc_number] => RE038117 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2003-05-06 [patent_title] => 'Trioxane dimer compound having antiproliferative and antitumor activities' [patent_app_type] => E1 [patent_app_number] => 09/717815 [patent_app_country] => US [patent_app_date] => 2000-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 54 [patent_no_of_words] => 17208 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/038/RE038117.pdf [firstpage_image] =>[orig_patent_app_number] => 09717815 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1363707 [patent_doc_number] => 06569874 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-05-27 [patent_title] => 'Thiazoles as factor Xa inhibitors' [patent_app_type] => B1 [patent_app_number] => 09/713002 [patent_app_country] => US [patent_app_date] => 2000-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 73335 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 1466 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/569/06569874.pdf [firstpage_image] =>[orig_patent_app_number] => 09713002 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 817267 [patent_doc_number] => 07411075 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2008-08-12 [patent_title] => 'Polymorphic form of atorvastatin calcium' [patent_app_type] => utility [patent_app_number] => 09/714351 [patent_app_country] => US [patent_app_date] => 2000-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3521 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/411/07411075.pdf [firstpage_image] =>[orig_patent_app_number] => 09714351 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1289719 [patent_doc_number] => 06632833 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-10-14 [patent_title] => '2-(2-methylphenyl)-3,4-dihydro-2H-pyrrole derivatives' [patent_app_type] => B1 [patent_app_number] => 09/700288 [patent_app_country] => US [patent_app_date] => 2000-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20296 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/632/06632833.pdf [firstpage_image] =>[orig_patent_app_number] => 09700288 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4339219 [patent_doc_number] => 06333415 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-25 [patent_title] => 'Intermediates and processes for the preparation of optically active octanoic acid derivatives' [patent_app_type] => 1 [patent_app_number] => 9/700181 [patent_app_country] => US [patent_app_date] => 2000-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5539 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/333/06333415.pdf [firstpage_image] =>[orig_patent_app_number] => 700181 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1521267 [patent_doc_number] => 06414003 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-02 [patent_title] => 'Oxazolone derivatives and their use as anti-helicobacter pylori agents' [patent_app_type] => B1 [patent_app_number] => 09/708542 [patent_app_country] => US [patent_app_date] => 2000-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27127 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 1336 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/414/06414003.pdf [firstpage_image] =>[orig_patent_app_number] => 09708542 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1475183 [patent_doc_number] => 06387935 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-14 [patent_title] => 'Polycyclic dihydrothiazoles having substituted alkyl radicals in the two-position, process for their preparation, and their use as pharmaceuticals' [patent_app_type] => B1 [patent_app_number] => 09/706351 [patent_app_country] => US [patent_app_date] => 2000-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11071 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 1508 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/387/06387935.pdf [firstpage_image] =>[orig_patent_app_number] => 09706351 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1478817 [patent_doc_number] => 06451833 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-17 [patent_title] => 'N-substituted (-imidazolyl-toluyl)pyrrole compounds for treatment of circulatory disorders' [patent_app_type] => B1 [patent_app_number] => 09/704389 [patent_app_country] => US [patent_app_date] => 2000-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16714 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 524 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/451/06451833.pdf [firstpage_image] =>[orig_patent_app_number] => 09704389 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1420723 [patent_doc_number] => 06515015 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-04 [patent_title] => 'Antidiabetic agents based on aryl and heteroarylacetic acids' [patent_app_type] => B1 [patent_app_number] => 09/695009 [patent_app_country] => US [patent_app_date] => 2000-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17130 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 817 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/515/06515015.pdf [firstpage_image] =>[orig_patent_app_number] => 09695009 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1418247 [patent_doc_number] => 06518299 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-11 [patent_title] => 'Substituted pyrrolidine compounds useful as neuraminidase inhibitors' [patent_app_type] => B1 [patent_app_number] => 09/692518 [patent_app_country] => US [patent_app_date] => 2000-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4853 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/518/06518299.pdf [firstpage_image] =>[orig_patent_app_number] => 09692518 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4373571 [patent_doc_number] => 06288236 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-11 [patent_title] => 'Benzimidazole compounds containing a benzoxazole or benzothiazole ring, and compositions and methods of use containing the same' [patent_app_type] => 1 [patent_app_number] => 9/688146 [patent_app_country] => US [patent_app_date] => 2000-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16394 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/288/06288236.pdf [firstpage_image] =>[orig_patent_app_number] => 688146 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7640172 [patent_doc_number] => 06395743 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-28 [patent_title] => 'HIV integrase inhibitors' [patent_app_type] => B1 [patent_app_number] => 09/689174 [patent_app_country] => US [patent_app_date] => 2000-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9194 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/395/06395743.pdf [firstpage_image] =>[orig_patent_app_number] => 09689174 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 614061 [patent_doc_number] => RE039420 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2006-12-05 [patent_title] => '1,2-Diphenylpyrrole derivatives, their preparation and their therapeutic uses' [patent_app_type] => reissue [patent_app_number] => 09/678218 [patent_app_country] => US [patent_app_date] => 2000-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 53160 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/039/RE039420.pdf [firstpage_image] =>[orig_patent_app_number] => 09678218 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1589450 [patent_doc_number] => 06482843 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-19 [patent_title] => 'Compounds and methods for use thereof in the treatment of cancer or viral infections' [patent_app_type] => B1 [patent_app_number] => 09/676407 [patent_app_country] => US [patent_app_date] => 2000-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13350 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/482/06482843.pdf [firstpage_image] =>[orig_patent_app_number] => 09676407 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 999702 [patent_doc_number] => 06911553 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-06-28 [patent_title] => 'Osteoblast-specific mitogens and drugs containing such compounds' [patent_app_type] => utility [patent_app_number] => 09/675943 [patent_app_country] => US [patent_app_date] => 2000-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 6615 [patent_no_of_claims] => 85 [patent_no_of_ind_claims] => 38 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/911/06911553.pdf [firstpage_image] =>[orig_patent_app_number] => 09675943 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1304646 [patent_doc_number] => 06620940 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-09-16 [patent_title] => 'Palladium-catalyzed cross-coupling chemistry on 3-chloro-4-halo-1,2,5-thiadiazole' [patent_app_type] => B1 [patent_app_number] => 09/671854 [patent_app_country] => US [patent_app_date] => 2000-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6969 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/620/06620940.pdf [firstpage_image] =>[orig_patent_app_number] => 09671854 [rel_patent_id] =>[rel_patent_doc_number] =>)